The intriguing role of FAP as a negative prognostic and positive indicative biomarker in melanoma is demonstrated by its positive association with survival outcome of anti-PD-1 treated melanoma patients, and its inverse association with prognosis in the absence of immunotherapy. This evidence concerns the gene FAP and melanoma.